Transforming Atopic Dermatitis Care: The Impact of Early Treatment – A DermTalks Webinar
We are pleased to share the recording of the DermTalks webinar “Transforming Atopic Dermatitis Care: The Impact of Early Treatment” featuring Prof. Dr. Jan Gutermuth, dermatologist and expert in inflammatory skin disorders. In this session, moderated by Dr. Klas Agerberg, Prof. Gutermuth explores the concept of Cumulative Life-Course Impairment (CLCI) in atopic dermatitis and the potential role of early intervention in altering disease progression.
We invite you to watch the recording to gain valuable clinical insights into the evolving approach to atopic dermatitis care and the role of early treatment in preventing cumulative disease burden.
Topics Covered
- The multidimensional disease burden of AD in adult and pediatric patients
- The meaning of Cumulative Life Course Impairment (CLCI) in AD
- Whether early intervention can shape the course of atopic dermatitis and prevent CLCI
- The link between early intervention and disease modification
- The clinical implications of early intervention
Speaker
Prof. Dr. Jan Gutermuth is the Head of the Dermatology Department at the University Hospital Brussels (Belgium) and a recognized expert in the treatment of inflammatory skin diseases, including atopic dermatitis. With extensive clinical and academic experience, Prof. Gutermuth currently serves as the President of the Royal Belgian Society of Dermatology and Venereology since March 2025, contributing to advancements in patient care and dermatologic research.
DermTalks Board
This webinar is part of the DermTalks Series 2.0, an unbranded educational initiative by Sanofi. The series is led by a board of dermatologists and aims to address current challenges, data gaps, and emerging trends in dermatology across North-European countries.
